Pharmacokinetics in foremilk and antimicrobial activity of cephapirin following intramammary administration in healthy and Staphylococcus aureus-infected cows

References

• *Anonymous. Decreto Legislativo n. 116 del 27/01/1992 (in Suppl. ordinario alla Gazz. Uff. n. 40, del 18 febbraio). Attuazione della direttiva (CEE) n. 609/86 in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici. [Legislative Decree No. 116 of 1/27/1992 (Suppl. ordinary to Gazz. Uff. No. 40, February 18). Implementation of Directive (EEC) No 609/86 on the protection of animals used for experimental and other scientific purposes] http://www.provincia.milano.it/export/sites/default/diritti_animali/informazioni_e_servizi/leggi_decreti_ordinanze/D.L._116-92_sperimentazione_animale.doc&sa=U&ei=tOZ_UragJY6akgWUi4DgBQ&ved=0CB4QFjAB&usg=AFQjCNFU2UbhRN6-dSmduYXLHvr7oUhT3A (accessed 08 November 2013) Milan, Italy,1992
   Google Scholar
• *Anonymous. Laboratory Handbook on Bovine Mastitis. National Mastitis Council. NMC Inc., Madison, WI, 1999
   Google Scholar
• *Anonymous. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals. 3rd Edn. Approved Standard M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2008
   Google Scholar
• *Anonymous. Committee for Medicinal Products for Veterinary Use, CVMP strategy on antimicrobials 2011–2015, 6 January 2011, EMA/CVMP/287420/2010 http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500100649&murl=menus/document_library/document_library.jsp&mid=WC0b01ac058009a3dc (accessed 15 February 2013). European Medicine Agency, London, UK, 2011
   Google Scholar
• Apparao MD, Ruegg PL, Lago A, Godden S, Bey R, Leslie K. Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium. Journal of Dairy Science 92, 2589–97, 2009 doi: 10.3168/jds.2008-1693
   PubMed Web of Science ®Google Scholar
• Barkema HW, Schukken YH, Zadoks RN. Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. Journal of Dairy Science 89, 1877–95, 2006 doi: 10.3168/jds.S0022-0302(06)72256-1
   PubMed Web of Science ®Google Scholar
• Cagnardi P, Villa R, Gallo M, Locatelli C, Carli S, Moroni P, Zonca A. Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows. Journal of Dairy Science 93, 4105–10, 2010 doi: 10.3168/jds.2010-3379
   PubMed Web of Science ®Google Scholar
• Constable PD, Morin DE. Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracycline. Journal of American Veterinary Medical Association 221, 103–8, 2002 doi: 10.2460/javma.2002.221.103
   PubMed Web of Science ®Google Scholar
• Constable PD, Morin DE. Treatment of clinical mastitis using antimicrobial susceptibility profiles for treatment decisions. Veterinary Clinics of North America: Food Animal Practice 19, 139–55, 2003
   PubMed Web of Science ®Google Scholar
• Cortinhas CS, Oliveira L, Hulland C, Santos MV, Ruegg PL. Minimum inhibitory concentrations of cephalosporin compounds and their active metabolites for selected mastitis pathogens. American Journal of Veterinary Research 74, 683–90, 2013 doi: 10.2460/ajvr.74.5.683
   PubMedGoogle Scholar
• Demon D, Ludwig C, Breyne K, Guédé D, Dorner JC, Froyman R, Meyer E. The intramammary efficacy of first generation cephalosporins against Staphylococcus aureus mastitis in mice. Veterinary Microbiology 160, 141–50, 2012 doi: 10.1016/j.vetmic.2012.05.017
   PubMed Web of Science ®Google Scholar
• Gehring R, Smith GW. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. Journal of Veterinary Pharmacology and Therapeutics 29, 237–41, 2006 doi: 10.1111/j.1365-2885.2006.00750.x
   PubMed Web of Science ®Google Scholar
• *Gibaldi M, Perrier D. Pharmacokinetics. Marcel Dekker Inc., New York, 1982
   Google Scholar
• Guérin-Faublée V, Carret G, Houffschmitt P. In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis. Veterinary Record 152, 466–71, 2003 doi: 10.1136/vr.152.15.466
   PubMed Web of Science ®Google Scholar
• McKellar QA, Sanchez Bruni SF, Jones DG. Pharmacokinetic/pharmacodynamics relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27, 503–14, 2004 doi: 10.1111/j.1365-2885.2004.00603.x
   PubMed Web of Science ®Google Scholar
• Moroni P, Pisoni G, Antonini M, Villa R, Boettcher P, Carli S. Antimicrobial drug susceptibility of Staphylococcus aureus from subclinical bovine mastitis in Italy. Journal of Dairy Science 89, 2973–76, 2006 doi: 10.3168/jds.S0022-0302(06)72569-3
   PubMed Web of Science ®Google Scholar
• Pol M, Ruegg PL. Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in Wisconsin. Journal of Dairy Science 90, 249–61, 2007 doi: 10.3168/jds.S0022-0302(07)72626-7
   PubMed Web of Science ®Google Scholar
• Roy JP, Descoteaux L, Dutremblay D, Beaudry F, Elsener J. Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus. Canadian Veterinary Journal 50, 1257–62, 2009
   PubMed Web of Science ®Google Scholar
• Saini V, McClure JT, Leger D, Dufour S, Sheldon AG, Scholl DT, Barkema HW. Antimicrobial use on Canadian dairy farms. Journal of Dairy Science 95, 1209–21, 2012 doi: 10.3168/jds.2011-4527
   PubMed Web of Science ®Google Scholar
• Salmon SA, Watts JL, Aarestrup FM, Pankey JW, Yancey RJ. Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark. Journal of Dairy Science 81, 570–8, 1997 doi: 10.3168/jds.S0022-0302(98)75610-3
   Google Scholar
• Sears PM, McCarthy KK. Management and treatment of staphylococcal mastitis. Veterinary Clinics of North America: Food Animal Practice 19, 171–85, 2003
   PubMed Web of Science ®Google Scholar
• Sørensen LK, Snor LK. Determination of cephalosporins in raw bovine milk by high-performance liquid chromatography. Journal of Chromatography A 882, 145–51, 2000 doi: 10.1016/S0021-9673(99)01317-5
   PubMed Web of Science ®Google Scholar
• Stockler RM, Morin DE, Lantz RK, Hurley WL, Constable PD. Effect of milk fraction on concentrations of cephapirin and desacetylcephapirin in bovine milk after intramammary infusion of cephapirin sodium. Journal of Veterinary Pharmacology and Therapeutics 32, 345–52, 2009a doi: 10.1111/j.1365-2885.2008.01048.x
   PubMed Web of Science ®Google Scholar
• Stockler RM, Morin DE, Lantz RK, Constable PD. Effect of milking frequency and dosing interval on the pharmacokinetics of cephapirin after intramammary infusion in lactating dairy cows. Journal of Dairy Science 92, 4262–75, 2009b doi: 10.3168/jds.2008-1916
   PubMed Web of Science ®Google Scholar
• Toutain PL, Del Castillo JRE, Bousquet-Melou A.: The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science 73, 105–14, 2002 doi: 10.1016/S0034-5288(02)00039-5
   PubMed Web of Science ®Google Scholar
• Zonca A, Gallo M, Locatelli C, Carli S, Moroni P, Villa R, Cagnardi P.: Cefquinome sulfate behavior after intramammary administration in healthy and infected cows. Journal of Dairy Science 94, 3455–61, 2011 doi: 10.3168/jds.2010-4109
   PubMed Web of Science ®Google Scholar